Expert Review of Pharmacoeconomics & Outcomes Research, Volume 18, Issue 3 (2018)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 18, Issue 3 (2018)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Volume 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Letter to the Editor

Letter
Rare diseases in Romania – a response to ‘transposition and implementation of EU rare diseases policy in Eastern Europe’
Emilia Severin
Pages: 233-234
Published online: 25 Apr 2018
CitationforRare diseases in Romania – a response to ‘transposition and implementation of EU rare diseases policy in Eastern Europe’ | Full Text | References | PDF (243.3 KB)
  • 640 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Optimizing skin and skin structure infection outcomes: considerations of cost of care
S. S. Almarzoky Abuhussain, K. J. Goodlet, M. D. Nailor & D. P. Nicolau
Pages: 235-244
Published online: 14 Mar 2018
AbstractforOptimizing skin and skin structure infection outcomes: considerations of cost of care | Full Text | References | PDF (736.1 KB)
  • 205 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Systematic review and benchmarking of Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) in oncology
Caitlyn T. Solem, Youngmin Kwon, Ruchit M. Shah, Abdalla Aly & Marc F. Botteman
Pages: 245-253
Published online: 05 Feb 2018
AbstractforSystematic review and benchmarking of Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) in oncology | Full Text | References | PDF (1.1 MB) | Supplemental
  • 331 Views
  • 20 CrossRef citations
  • 0Altmetric
Review
A systematic review of economic evaluations of tyrosine kinase inhibitors of vascular endothelial growth factor receptors, mammalian target of rapamycin inhibitors and programmed death-1 inhibitors in metastatic renal cell cancer
Panagiotis Petrou
Pages: 255-265
Published online: 13 Mar 2018
AbstractforA systematic review of economic evaluations of tyrosine kinase inhibitors of vascular endothelial growth factor receptors, mammalian target of rapamycin inhibitors and programmed death-1 inhibitors in metastatic renal cell cancer | Full Text | References | PDF (996.3 KB)
  • 162 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
A systematic review of health economic models and utility estimation methods in schizophrenia
Bertalan Németh, Ahmad Fasseeh, Anett Molnár, István Bitter, Margit Horváth, Kristóf Kóczián, Árpád Götze & Balázs Nagy
Pages: 267-275
Published online: 27 Jan 2018
AbstractforA systematic review of health economic models and utility estimation methods in schizophrenia | Full Text | References | PDF (1 MB)
  • 530 Views
  • 28 CrossRef citations
  • 0Altmetric
Review
Cost-effectiveness thresholds: methods for setting and examples from around the world
André Soares Santos, Augusto Afonso Guerra-Junior, Brian Godman, Alec Morton & Cristina Mariano Ruas
Pages: 277-288
Published online: 27 Feb 2018
AbstractforCost-effectiveness thresholds: methods for setting and examples from around the world | Full Text | References | PDF (1.2 MB) | Supplemental
  • 928 Views
  • 32 CrossRef citations
  • 0Altmetric

Original Research

Article
Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?
Gertruud Haitsma, Himanshu Patel, Parthasarathi Gurumurthy & Maarten J. Postma
Pages: 289-296
Published online: 26 Feb 2018
AbstractforAccess to anti-cancer drugs in India: is there a need to revise reimbursement policies? | Full Text | References | PDF (735 KB) | Supplemental
  • 416 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Most important barriers and facilitators of HTA usage in decision-making in Europe
K.L. Cheung, S.M.A.A. Evers, H. De Vries, P. Levy, S. Pokhrel, T. Jones, M. Danner, J. Wentlandt, L. Knufinke, S. Mayer & M. Hiligsmann
Pages: 297-304
Published online: 05 Jan 2018
AbstractforMost important barriers and facilitators of HTA usage in decision-making in Europe | Full Text | References | PDF (1.2 MB) | Supplemental
  • 477 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis
Raquel Sanchez-Santos, Esther Mariño Padin, Daniel Adam, Oleg Borisenko, Sergio Estevez Fernandez, Ester Carrera Dacosta, Sonia González Fernández, Juan Turnes Vazquez, Juan Carlos Ruiz de Adana & Felipe de la Cruz Vigo
Pages: 305-314
Published online: 30 Nov 2017
AbstractforBariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis | Full Text | References | PDF (1.1 MB)
  • 210 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Direct costs for nonsurgical management of Chronic Pancreatitis in a tertiary care teaching hospital
Nagesh Kamat, Ganesh Pai, Surulivel Rajan Mallayasamy, Asha Kamath & Rajasulochana S
Pages: 315-320
Published online: 12 Oct 2017
AbstractforDirect costs for nonsurgical management of Chronic Pancreatitis in a tertiary care teaching hospital | Full Text | References | PDF (777.3 KB) | Supplemental
  • 110 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness analysis of infliximab, adalimumab, golimumab and vedolizumab for moderate to severe ulcerative colitis in Spain
Cristina Trigo-Vicente, Vicente Gimeno-Ballester, Raquel Montoiro-Allué & Alejandro López-Del Val
Pages: 321-329
Published online: 02 Dec 2017
AbstractforCost-effectiveness analysis of infliximab, adalimumab, golimumab and vedolizumab for moderate to severe ulcerative colitis in Spain | Full Text | References | PDF (989.3 KB) | Supplemental
  • 850 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness analysis of the use of high-flow oxygen through nasal cannula in intensive care units in NHS England
Emily Eaton Turner & Michelle Jenks
Pages: 331-337
Published online: 05 Dec 2017
AbstractforCost-effectiveness analysis of the use of high-flow oxygen through nasal cannula in intensive care units in NHS England | Full Text | References | PDF (1.1 MB) | Supplemental
  • 464 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment
Jörg Mahlich, Isao Kamae & Rosarin Sruamsiri
Pages: 339-348
Published online: 03 Nov 2017
AbstractforPharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment | Full Text | References | PDF (825.2 KB)
  • 272 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles